These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7697782)

  • 1. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation.
    Solange A
    Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
    Nagao S; Sato K; Osada Y
    Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
    Nagao S; Sato K; Osada Y
    Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic immunomodulators and synthetic vaccines.
    Leclerc C; Vogel FR
    Crit Rev Ther Drug Carrier Syst; 1986; 2(4):353-406. PubMed ID: 3103928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
    Leclerc C; Chedid L
    Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mRNA responses in human macrophages activated by interferon-gamma and muramyl dipeptide.
    Vermeulen MW; David JR; Remold HG
    J Immunol; 1987 Jul; 139(1):7-9. PubMed ID: 3108404
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological activity of new tuftsin derivatives--induction of phagocytosis.
    Wardowska A; Dzierzbicka K; Trzonkowski P; Myśliwski A
    Acta Pol Pharm; 2006; 63(5):378-81. PubMed ID: 17357588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.
    Wahl SM; Wahl LM; McCarthy JB; Chedid L; Mergenhagen SE
    J Immunol; 1979 Jun; 122(6):2226-31. PubMed ID: 221582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
    Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
    J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
    Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D; Jeannin JF; Lagadec P; Martin F
    J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in purine metabolism in the macrophages of mice exposed to a new synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu; Tarakhovskiĭ AM; Andronova TM
    Biull Eksp Biol Med; 1985 Jun; 99(6):685-7. PubMed ID: 2990603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
    Mizuno K; Okamoto H; Horio T
    J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.